Printer Friendly Version
Douglas Gray brings to his clients a broad range of experience in the practice of corporate law, concentrating in the areas of mergers and acquisitions, corporate governance, strategic alliances, and commercial ventures. In addition, he enjoys an active collaborations practice, centered on negotiating licensing, joint venture and development agreements relating to intellectual property rights. He is the Co-Chair of the Firm's Life Science Practice Group focusing on medical device, pharmaceutical and healthcare related companies and products.
Douglas' work in acquisitions, dispositions, joint ventures and other transactions involves representation of individual investors, management teams, corporate buyers and sellers, venture capitalists and private equity firms. This varied representation provides him with a unique understanding of the likely concerns of each party in a sophisticated transaction so that he is well-suited to assist clients in planning and implementing their strategies as well as crafting creative, but cost-effective, solutions to their concerns.
Douglas is listed as one of the few lawyers in the Corporate/Commercial practice in the Rhode Island Section of Chambers USA: America's Leading Lawyers for Business and has been since 2007, he was named a Super Lawyer since 2011 and has been listed in the Corporate Law section of The Best Lawyers in America for 2010 through 2019 including the 2014-15 Providence Corporate Law "Lawyer of the Year." Douglas was also very involved with non-profit corporations, he is the Co-Chair of the Firm's Pro Bono Committee and was the Pro Bono Partner for 2013 for the Providence office. In addition, Douglas has received Martindale Hubbell's highest rating of AV.
News, Events, Notable Matters, and More
Showing Results for
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.